Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Singular Genomics Sys Q4 2023 GAAP EPS $(0.32) Beats $(0.36) Estimate, Sales $1.081M Beat $731.333K Estimate

Author: Benzinga Newsdesk | March 18, 2024 04:38pm
Singular Genomics Sys (NASDAQ:OMIC) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.36) by 11.11 percent. The company reported quarterly sales of $1.081 million which beat the analyst consensus estimate of $731.333 thousand by 47.81 percent. This is a 41.31 percent increase over sales of $765.000 thousand the same period last year.

Posted In: OMIC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist